S&P 500 Futures
(0.12%) 5 333.50 points

Dow Jones Futures
(0.08%) 40 168 points

Nasdaq Futures
(0.18%) 18 669 points

Oil
(0.25%) $80.26

Gas
(1.83%) $2.67

Gold
(0.89%) $2 438.80

Silver
(2.03%) $31.90

Platinum
(-0.64%) $1 083.00

USD/EUR
(-0.09%) $0.919

USD/NOK
(-0.02%) $10.67

USD/GBP
(0.00%) $0.787

USD/RUB
(0.06%) $91.02

Realtime updates for NOXXON Pharma NV [ALNOX.PA]

Exchange: EURONEXT Industry: Biotechnology

Last Updated31 Dec 1970 @ 19:00

25% discount on Stockinvest.us - Use code: Podcast

0.00% € 0.0410

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

NOXXON Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany...

Stats
Today's Volume	10.21M
Average Volume	4.35M
Market Cap	0.00
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.187
ATR14	€0 (0.00%)

NOXXON Pharma NV Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NOXXON Pharma NV Financials

Annual	2021
Revenue:	€0.00
Gross Profit:	€0.00 (0.00 %)
EPS:	€-45.99

FY	2021
Revenue:	€0.00
Gross Profit:	€0.00 (0.00 %)
EPS:	€-45.99

FY	2020
Revenue:	€0.00
Gross Profit:	€0.00 (0.00 %)
EPS:	€-32.16

FY	2019
Revenue:	€0.00
Gross Profit:	€-1.03M (0.00 %)
EPS:	€-7.72

Financial Reports:

No articles found.

NOXXON Pharma NV Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NOXXON Pharma NV

NOXXON Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. It is also developing NOX-E36, which has completed Phase 1/2 clinical trial for the treatment of diabetic nephropathy. The company has a collaboration agreement with Merck & Co. Inc. to study NOX-A12 combined with Keytruda/pembrolizumab inhibitor antibody in patients with metastatic solid tumors. NOXXON Pharma N.V. was founded in 1997 and is based in Berlin, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.